Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Sharon Labreche
VICE PRESIDENT, GLOBAL TALENT ACQUISITION, ALNYLAM
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
Louise Lagerqvist
PARTNERING MANAGER, US, MEDINCELL
MedinCell
Jacou, France
Shoupeng Lai
EVP/ CO-FOUNDER, LEADS BIOLABS
LEADS BioLabs
Nanjing, China
Thomas Lake
SVP, VACCINE DEVELOPMENT ALLIANCES, VAXXAS
Beyond the Needle: Novel Approaches to Vaccine Delivery
Sydney, Australia
Janet Lambert, MBA
CEO, ARM
Patient Engagement in Gene and Cell Therapy: What is Different?
Washington DC, District Of Columbia, United States
Jordan Lancaster, PhD
CEO, AVERY THERAPEUTICS, INC
Avery Therapeutics, Inc
Tucson, Arizona, United States
Gerardo Lancia, MBA
HEAD OF TECH TRASFER, CLUSTER & SPECIAL PROJECTS - LAZIO INNOVA SPA, LAZIO INNOVA SPA
Invest in Lazio
Rome, Italy
Paul Langley
HEALTH ECONOMIST, MAIMON RESEARCH LLC
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Tucson, Arizona, United States
James Lanthier
CEO, MINDSET PHARMA
Mindset Pharma
Toronto, Ontario, Canada
Donna LaVoie
PRESIDENT & CEO, LAVOIEHEALTHSCIENCE
The Power of Content in Your Virtual Presentation – How to Create Your Company Presentation in Just 15 Slides
Boston, Massachusetts, United States
Matthew Lawrence, MD, PhD
CHIEF EXECUTIVE OFFICER & CHIEF SCIENTIFIC OFFICER, VIRSCIO
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
New Haven, Connecticut, United States
David Leach
CEO, LIGNAMED, LLC
LignaMed, LLC
Philadelphia, Pennsylvania, United States
Thomas Leary
PROTEIN PRODUCT SPECIALIST, DNASTAR, INC.
DNASTAR Inc.
Madison, Wisconsin, United States
Seth Lederman
CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS HOLDING CORP/.
Tonix Pharmaceutical Holding Corp.
New York, New York, United States
Johnsee Lee, MBA, PhD
FOUNDER AND CEO, PERSONAL GENOMICS, INC.
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
Personal Genomics, Inc.
Zhubei, Hsinchu, Taiwan
Yuta Lee, MBA
CEO, ACCELERATED BIOSCIENCES
Accelerated Biosciences
Carlsbad, California, United States
Kyuho Lee
CEO, ATOMICS AI
Atomics AI
Cheongju, Korea, Republic of
Bora Lee
IP & BD MANAGER, BIONOXX
Bionoxx Inc.
Yangsan-si, Korea, Republic of
Victor Lee
CEO, VICTOGEN
VictoGen
Thousand Oaks, California, United States
Merissa Lee, BSc
BD SPECIALIST, SYNCORE BIOTECHNOLOGY
SynCore Biotechnology
Taipei, Taiwan
Peter Lee
CORPORATE VICE PRESIDENT, AI AND RESEARCH, MICROSOFT
The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable
Seattle, Washington, United States
Arlinda Lee, PhD
ANALYST , CANACCORD GENUITY
Bispecific Antibodies Catching Fire
New York , New York, United States
Kevin Lee, PhD
CEO, BICYCLE THERAPEUTICS
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Lexington, Massachusetts, United States
Christian Leisner
CEO, CDR-LIFE
CDR-Life
Schlieren - Zurich, Switzerland
Anna Lembke, MD
ASSOCIATE PROFESSOR OF PSYCHIATRY AND BEHAVIORAL SCIENCES, STANFORD UNIVERSITY MEDICAL CENTER
Disruptive Thinking: New Tools To Transform Addiction Treatment
Christine Lemke, PhD
EVIDATION HEALTH, CO-FOUNDER AND PRESIDENT, EVIDATION HEALTH
The Emerging Role of Digital Biomarkers in Cognitive Impairment
San Mateo, California, United States
Stephan Lensky
COO/CBO, EPIMAB BIOTHERAPEUTICS
EpimAb Biotherapeutics
NEW BRAINTREE, Massachusetts, United States
Stephanie Leouzon
PARTNER AND HEAD OF TORREYA EUROPE, TORREYA
Is It Time to Reconsider M&A’s Role in Portfolio Building?
London, United Kingdom
Nick Leschly
PRESIDENT & CEO, BLUEBIRD BIO
Next Generation Orphan Drug Incentives
Cambridge, Massachusetts, United States
Rachael Lester
VICE PRESIDENT OF CORPORATE DEVELOPMENT, HARPOON THERAPEUTICS
Restarting the Bioeconomy: What IPO and Alliance Data tell us
United States
Kirsten Leute
PARTNER, UNIVERSITY RELATIONS, OSAGE UNIVERSITY PARTNERS
Derisking Early Research and Increasing Likelihood of Clinical Success
Bala Cynwyd, Pennsylvania, United States
Matthieu Leuwers
CHIEF BD OFFICER, PROVEPHARM LIFE SOLUTIONS
Provepharm Life Solutions
Marseille, France
Jeremy Levin, MB BChir, D. Phil
CHAIRMAN OF THE BOARD OF DIRECTORS AND CHIEF EXECUTIVE OFFICER, OVID THERAPEUTICS INC.
Biotech’s Finest Hour
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
New York, New York, United States
Cynthia Li
DIRECTOR, BUSINESS DEVELOPMENT, EXELIXIS
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
Alameda, California, United States
Mike Liccardo
VP CORP. DEV. & CFO, SHAREVAULT
ShareVault
Los Gatos, CA, California, United States
Jay Lichter, PhD
MANAGING DIRECTOR, AVALON VENTURES; PRESIDENT & CEO, COI PHARMACEUTICALS, AVALON VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
La Jolla, California, United States
Emmanuel Ligner
PRESIDENT & CEO, CYTIVA
Cytiva
Chern-Hooi Lim, PhD
CEO, NEW IRIDIUM
New Iridium
Boulder, Colorado, United States
George Lin
EVP & CFO, HUA MEDICINE
Hua Medicine
Hong Kong, Hong Kong
Erick Lin
MEDICAL DIRECTOR, MEDICAL AFFAIRS LEAD, BLUE CROSS BLUE SHIELD ASSOCIATION
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
Temple City , California, United States
Klaus Lindpaintner
CSO/CMO, INTERVENN
InterVenn
South San Francisco, California, United States
Evan Lippman
HEAD OF CORPORATE DEVELOPMENT AND BD FINANCE, GLOBAL BUSINESS DEVELOPMENT, TAKEDA PHARMACEUTICAL COMPANY LIMITED
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Cambridge, Massachusetts, United States
Donald Lo, PhD
DIRECTOR, DIVISION OF PRECLINICAL INNOVATION, THERAPEUTIC DEVELOPMENT BRANCH, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NATIONAL INSTITUTES OF HEALTH
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
United States
Christopher Locher
CEO, VERSATOPE THERAPEUTICS, INCORPORATED
Versatope Therapeutics, Inc.
Lowell, Massachusetts, United States
Rob Long
EXECUTIVE DIRECTOR, UPLIFTING ATHLETES
Uplifting Athletes
Chester Springs, Pennsylvania, United States
Katrina Loomis
EXECUTIVE DIRECTOR, HEAD OF EMERGING PORTFOLIO, EMERGING SCIENCE & INNOVATION, PFIZER
Digitizing the Genome: Enabling New Models for Population-Scale Genomics
Ted Love, MD
PRESIDENT & CHIEF EXECUTIVE OFFICER, GLOBAL BLOOD THERAPEUTICS
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
Leading Through Crisis: Speaking Up and Out on Equity, Diversity, and Inclusion Issues Impacting our World
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
Jeffrey Lu
CEO AND CO-FOUNDER, ENGINE BIOSCIENCES
Engine Biosciences
San Carlos, California, United States
James Lu, MD, PhD
CO-FOUNDER & CHIEF SCIENTIFIC OFFICER, HELIX
Helix
Digitizing the Genome: Enabling New Models for Population-Scale Genomics
San Mateo, California, United States
Heinz Lubenau
CHIEF EXECUTIVE OFFICER, VAXIMM AG
Vaximm AG
Basel, Switzerland
Shun Luo
CEO, CHAIRMAN, JIANSHUN BIOSCIENCES
Thousand Oaks Biopharmaceuticals
Shanghai, China
Tia Lyles-Williams, MSc
FOUNDER & CEO, LUCASPYE BIO
LucasPye BIO, LLC
Elizabeth, New Jersey, United States
Steven Lynum
EXECUTIVE DIRECTOR (BASED IN USA), PHC CORPORATION
PHC Corporation
Livingston, New Jersey, United States
Load More